Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
EPHA1 belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. Additionally we are shipping Ephrin Type A Receptor 1 Proteins (24) and Ephrin Type A Receptor 1 Kits (23) and many more products for this protein.
Showing 10 out of 159 products:
Human Monoclonal EPHA1 Primary Antibody for IHC, ELISA - ABIN966070
Pasquale: Eph receptor signalling casts a wide net on cell behaviour. in Nature reviews. Molecular cell biology 2005
Show all 2 Pubmed References
Human Polyclonal EPHA1 Primary Antibody for IHC (p), WB - ABIN391884
Hillier, Fulton, Fulton, Graves, Pepin, Wagner-McPherson, Layman, Maas, Jaeger, Walker, Wylie, Sekhon, Becker, OLaughlin, Schaller, Fewell, Delehaunty, Miner, Nash, Cordes, Du, Sun, Edwards et al.: The DNA sequence of human chromosome 7. ... in Nature 2003
Show all 3 Pubmed References
Human Polyclonal EPHA1 Primary Antibody for CyTOF, FACS - ABIN4899970
Gordon, Kochkodan, Blatt, Lin, Kaplan, Johnston, Swindell, Hoover, Schlosser, Elder, Gudjonsson, Getsios: Alteration of the EphA2/Ephrin-A signaling axis in psoriatic epidermis. in The Journal of investigative dermatology 2013
Data show that Ephrin B3 (show EFNB3 Antibodies) was concomitantly expressed with EphA2 (show EPHA2 Antibodies) and Ephrin A1 (show EFNA1 Antibodies) with higher Ephrin B3 (show EFNB3 Antibodies) levels found in non-squamous than in squamous tumors.
Results show that EPHA1 expression is up-regulated in ovarian cancer (OC) cells and provide evidence that it may promote the aggression of some OC cells.
EPHA1 suppresses spreading and adhesion of HRT18 colorectal cancer cells through deactivation of ERK (show EPHB2 Antibodies) and JNK (show MAPK8 Antibodies) signaling pathways.
Data indicate that EphA1 protein may be a new marker for the prognosis of clear cell renal cell carcinoma (show MOK Antibodies).
High expression of EphA1 was associated with metastasis and recurrence in Gastric Cancer.
This study suggests EPHA1 (rs11771145) interferes with the pathological alteration of the hippocampus and the lateral occipitotemporal and inferior temporal gyri throughout the Alzheimer's disease process, leading to a lower risk of Alzheimer's disease.
EphrinA1 plays an important role in the TNF-alpha (show TNF Antibodies)-mediated adhesion of monocytes to endothelial cells.
Lack of ephrin receptor A1 is a favorable independent prognostic factor in clear cell renal cell carcinoma (show MOK Antibodies).
two states of the EphA1 transmembrane helix dimer
Suggest EphA1 receptor may have roles in carcinogenesis and progression of prostate cancer.
Activation of EphA1-Epha receptor axis attenuates diabetic nephropathy in mice.
These findings suggest that the ternary complex of EphA, FGFR (show FGFR2 Antibodies) and FRS2alpha (show FRS2 Antibodies) formed by ligand stimulation regulates self-renewal and differentiation of mouse embryonic neural stem/progenitor cells
Whole-mount in situ hybridization revealed overlapping expression of the Epha1 receptor and its high-affinity ligands ephrin A1 (Efna1 (show EFNA1 Antibodies)) and ephrin A3 (Efna3 (show EFNA3 Antibodies)) in the primitive streak and the posterior paraxial mesoderm during early mouse development.
expression of Eph A1, A2, A4, and A7 was strongly detected in endometrial epithelial cells during early pregnancy.
This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. This gene is expressed in some human cancer cell lines and has been implicated in carcinogenesis.
eph tyrosine kinase 1
, ephrin type-A receptor 1
, erythropoietin-producing hepatoma amplified sequence
, erythropoietin-producing hepatoma receptor
, oncogene EPH
, soluble EPHA1 variant 1
, soluble EPHA1 variant 2
, tyrosine-protein kinase receptor EPH
, embryonic stem cell kinase
, tyrosine-protein kinase receptor ESK
, ephrin receptor EphA1
, protein tyrosine kinase EphA9